Clinical Trials Browser

INDUSTRY × Has results × prexasertib × Clear all

NCT03414047 2022-08-19

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer

Phase 2 Completed

172 enrolled 19 charts

Ovarian Neoplasms

NCT02735980 2020-03-17

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

Phase 2 Completed

133 enrolled 20 charts

Small Cell Lung Carcinoma